KPRX
Kiora Pharmaceuticals Inc
NASDAQ: KPRX · HEALTHCARE · BIOTECHNOLOGY
$2.44
+3.83% today
Updated 2026-05-01
Market cap
$10.53M
P/E ratio
—
P/S ratio
0.14x
EPS (TTM)
$-2.64
Dividend yield
—
52W range
$2 – $4
Volume
0.6M
Kiora Pharmaceuticals Inc (KPRX) Earnings
Quarterly earnings history, analyst estimates, and stock price reaction.
EPS beat streak
4 of 8
Last 8 quarters
Avg EPS surprise
-17.0%
Last 4 quarters
Revenue YoY growth
—
Most recent quarter
EPS YoY growth
-43.4%
Most recent quarter
When is the next earnings report?
Reporting date
December 31, 2025
Consensus EPS estimate
$-0.44
Fiscal period ending
2025-12-31
Earnings surprise history (last 12 quarters)
Beat estimate Missed estimate
Quarterly EPS and revenue trend
Quarterly revenue EPS (diluted)
How the stock reacts to earnings
Avg 1-day reaction
+1.8%
Last 2 reports
Positive reaction rate
100%
2 of 2 quarters
Largest single-day move
+3.2%
2026-03-31
| Report date | EPS actual | Surprise | Close before | Close after | 1-day reaction |
|---|---|---|---|---|---|
| 2026-03-31 | $-1.73 | — | $1.89 | $1.95 | +3.2% |
| 2025-11-07 | $0.01 | +116.7% | $2.32 | $2.33 | +0.4% |
Quarterly earnings history
| Fiscal quarter ending | EPS estimate | EPS actual | Surprise | Revenue | YoY revenue |
|---|---|---|---|---|---|
| 2026-03-31 | — | $-1.73 | — | — | — |
| 2025-12-31 | $-0.44 | — | — | — | — |
| 2025-09-30 | $-0.06 | $0.01 | +116.7% | — | — |
| 2025-06-30 | $-0.06 | $-0.54 | -800.0% | — | — |
| 2025-03-31 | $-0.77 | $-0.52 | +32.5% | — | — |
| 2024-12-31 | $-0.74 | $-1.21 | -63.2% | $-15.95M | -5719.4% |
| 2024-09-30 | $-0.76 | $-0.81 | -6.6% | — | — |
| 2024-06-30 | $-0.86 | $-0.53 | +38.4% | $20000.00 | — |
| 2024-03-31 | $-0.07 | $0.38 | +642.9% | $16.00M | — |
| 2023-12-31 | $-0.42 | $-0.47 | -11.9% | $283872.00 | — |
| 2023-09-30 | $-0.35 | $-0.89 | -154.3% | — | — |
Frequently asked questions
When does Kiora Pharmaceuticals Inc report next earnings?
Kiora Pharmaceuticals Inc (KPRX) is scheduled to report earnings on December 31, 2025. The consensus EPS estimate is $-0.44.
Has Kiora Pharmaceuticals Inc beaten earnings estimates?
Kiora Pharmaceuticals Inc has beaten Wall Street EPS estimates in 4 of its last 8 quarterly reports, with an average EPS surprise of -17.0% over the last 3 quarters.
How does KPRX stock react to earnings?
KPRX stock has moved an average of +1.8% in the trading day following earnings over its last 2 reports, with positive reactions in 100% of those quarters.